Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further
Credit Suisse sees the Bristol-Myers Squibb gap with Merck getting even worse, even though it still has robust I-O franchise estimates for Bristol-Myers.
Credit Suisse sees the Bristol-Myers Squibb gap with Merck getting even worse, even though it still has robust I-O franchise estimates for Bristol-Myers.
August 5, 2016: Markets opened higher Friday following the report of 255,000 new U.S. jobs added in July. The financial and tech sectors led the gainers today, the former likely on improved…
Bristol-Myers Squibb shares took a nosedive early Friday's following an update in its late-stage Checkmate trial. But Bristol-Myer's failure was a big win for Merck.
Merck reported better-than-expected second-quarter 2016 results before markets opened Friday morning.
The short interest data have been released for the July 15 settlement date. For the selected pharmaceutical stocks, short interest was mixed.
Overall, one-third of the Dow Jones Industrial Average is reporting this week, and this has the potential to sustain the run that the Dow has made since the Brexit vote.
The June 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest decreased.
July 6, 2016: Markets opened lower again Wednesday, following international markets that traded lower overnight. The British pound posted a new 31-year low against the dollar before climbing back a little. The…
The broad markets are recovering in the wake of the Brexit and it really appears to be one big head fake. We are also realizing that the Brexit was a great opportunity…
June 29, 2016: Markets opened higher again Wednesday and every sector is again posting a gain as the closing bell approaches. A drawdown in U.S. crude oil inventories coupled with a weaker…
The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials.…
June 17, 2016: Markets opened lower again Friday after a somewhat disappointing report on U.S. housing starts. St. Louis Fed president James Bullard suggested that interest rate hikes may be far less…
June 16, 2016: Markets opened lower Thursday but equities showed some spunk by trading on an upward trend for nearly the whole day. Asian and European markets traded lower and economics data…
Merck and Afferent Pharmaceuticals reportedly have signed a definitive agreement under which the former will acquire the latter.
The May 31 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.